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Abstract
Purpose. Chondrosarcoma (CS) most commonly involves the pelvis.The factors that in¯ uence local and systemic control
of pelvic CS and the functional outcome should be evaluated.
Patients. Fifty-one patients (37 males and 14 females; mean age, 39.4 years) with pelvic CS were included in this
retrospective study.
Methods. The tumor stage,surgical treatment,surgical margin achieved,complications,incidenceof local recurrence(LR),
incidence of distant metastases, and the oncologic and functional status were evaluated. Oncologic outcome was estimated
by the method of Kaplan and Meier, and the functional status was scored according to Musculoskeleral Tumor Society
(MSTS) criteria. Analysis of variance was used to determine the factors that in¯ uence the oncologic and functional
outcome.
Results. Surgical stages were IA in three cases, IB in 23, IIB in 23, and III in two. Hemipelvectomy (H) was performed in
13 cases, internal hemipelvectomy (IH) with endoprosthetic replacement in 17, and continuity resection (CR) in 23.Two
patients received IH and CR, one due to LR, and one due to instability. Radical or wide margins were achieved in 27 cases,
marginal margins in 16, and intralesional margins in eight. Local complication required additional surgery in 10 cases due
to local infections and/or hematomas.Two patients died perioperatively. In 48 out of the 49 remaining patients, follow-up
was available with a mean duration of 73.4 months (range,4± 229 months).Twenty patients died of the disease, two patients
are alive with metastases, four patients are disease free after LR, and 22 patients show no evidence of the disease. LR
occurred in 10 cases (20.4%), and 17 patients (34.6%) developed distant metastases. Functional evaluation of the 28
survivors revealed good and excellent results in 19 cases, fair in three and poor in six.The mean MSTS score of all survivors
was 69.2%, after H it was 37.6%, after IH was 61.4%, and after CR was 79.5%.
Conclusion. In pelvic chondrosarcoma, survival was determined by the tumor stage and the surgical margin achieved.The
incidence of LR was in¯ uenced by the surgical margin achieved, whereas the incidence of distant metastases was influenced
by the tumor stage. The best oncologic results in chondrosarcoma involving the innominate bone could be found in
low-grade tumors, and the best functional results after continuity resection and restoration of the pelvic girdle.
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Introduction
Chondrosarcoma is a malignant tumor, con-
sisting of cartilaginous tissue without osteoid, and
accounts for approximately 20% of bone
sarcomas.
1± 3 The tumor arises predominantly in
the middle-aged population and occurs most
commonly in the pelvis and the upper end of the
femur.
1± 7
Primary bonesarcomas of the pelvis are considered
to have a worseprognosiscomparedwith thoselocated
in the long bones.
8± 14 There exist several reports of
chondrosarcoma involving the innominate bone, and
most of them have been focused primarily on
reconstruction surgery.
4± 7,14± 16
However, the prognosis of this common pelvic
tumor is described by only a few authors.
6,7,9± 11,15
Since chemotherapy and irradiation are not effec-
tive, surgery achieving an adequate, i.e. wide, margin
is currently the only known effective treatment of
chondrosarcoma.
However, in pelvic lesions,and adequate margin is
often not feasible because of the extent of the tumor
and the lack of compartimental barriers. Frequent
local and/or systemic failures after surgical treatment
complicate the outcome in these patients.
The purpose of this study was to de® ne factors
that in¯ uence local and systemic control of pelvic
chondrosarcoma and to evaluate the functional
results.
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Patients
Fifty-one patients with chondrosarcomainvolving the
innominatebonewere treated between October 1978
and April 1998.There were 37 males and 14 females
with an average age of 39.4 years (range,12± 64 years).
The age distribution is shown in Figure 1.
The anatomical origin of the tumor was located in
the illium in 26 cases, in the acetabular region in 21,
and in the pubis or ischium in four cases. According
to the surgical staging system of the Musculoskeletal
Tumor Society (MSTS),
17there were three stage IA,
23 stage IB, 23 stage IIB, and two stage III lesions
(Table 1).
Seven patients, three in stage IB, three stage IIB,
and one in stage III, had previous surgical treatment
in other institutions and presented with local recur-
rence. the median time to local recurrence in these
cases was 48 months (range, 5± 180 months).
The tumor volume was calculated according to the
method of Go È bel et al.
18 Tumors with a volume
‡ 500 ml were de® ned as large tumors,and < 500 ml
were de® ned as small tumors.There were 21 small
and 30 large tumors.The average tumor volume was
510 ml (range, 50± 950 ml).
Treatment
Fifty-three surgical procedures were performed and
divided into three groups:23 patients have undergone
continuity resection (CR) of the tumor with or
without restoration of the pelvic girdle (Fig. 2).The
different types of CR were classi® ed according to
Enneking and Dunham.
5 Internal hemipelvectomy
(IH) and endoprosthetic replacement was performed
in 17 cases, when the tumor involved the acetabulum
and the ilium or the pubis (Fig. 3). Hemipelvectomy
(H) was necessaryin 13 cases when the tumorinvaded
the iliac vessels or the sciatic nerve and, when sacri-
® ying a large amount of muscle, leaves the leg with
poor function.
Two patients received, primarily, a CR and,
secondarily,IH; in one case due to a local recurrence
and in one due to instability after CR. Table 2
summarizes the different types of resections and
reconstructions.
Methods
Fifty patients could be followed-up routinely from
the time of surgery to the time either of their death or
the date of their most recentfollow-up.In onepatient,
follow-up was not available. The screening for local
recurrence and distant metastases includes X-ray of
the chest and of the pelvis, and computed tomog-
raphy (CT) scan of the pelvis. Patients with high-
grade tumors (stage II) were controlled every 3
monthsfor 2 years,and after this time twice a year for
a further 3 years. In low-grade tumors, the screening
was performed twice a year over a period of 5 years.
The mean follow-up was 73.4 months (range,
4± 229 months). Data for this report was obtained
from hospital records,maintained oncologic® les and
the clinicalexamination of the most recentfollow-up.
These include the different types of resections and
reconstructions,the surgical margins achieved,
17 the
tumor volume, the complications and need for
re-operation,incidenceof local recurrenceand distant
metastases, and the actual oncologic and functional
status.
Excluding the two patients with stage III tumors,
the Fisher exact test was used to comparethe surgical
margin obtained and the surgical treatment group
(i.e. CR, IH, H), the surgical margins obtained and
the incidence of local recurrenceand metastases, the
tumor volume and the surgical margin obtained, as
well as the incidence of local recurrence and distant
metastases, and the need for re-operation and the
Fig. 1. Age distribution of 51 patients with pelvic chondrosar-
coma.
Table 1. Stage and origin of 51 patients with pelvic chondrosarcoma
Origin of the tumor
Stage Ileum Acetabulum Pubis or ischium
IA 3 3
IB 23 15 7 1
IIB 23 10 10 3
III 2 1 1
å 51 26 21 4
162 R.J.Wirbel et al.surgicaltreatment group.A p value less than 0.05 was
considered signi® cant.
Using analysis of variance, the oncologic outcome
was compared with the tumor stage, and the tumor
volume, the origin of the tumor, the performed
surgicalprocedure,and the surgicalmargin obtained.
Overall survival was estimated by the method of
Kaplan and Meier.
19
The functionaloutcomeobtained at the last clinical
follow-up of the survivors was rated according to the
most recent system of the MSTS.
20 This system
includes the six following categories: pain, function
of the hip joint, emotional acceptance, supports,
walking ability, and gait analysis. A maximum of ® ve
points for each factor produces the maximum scores
of 30 points. The patient’s total score is divided by
30,resultingin a functionalevaluation rate.The rating
was considered excellent if ® ve of the six factors
scored ® ve points, independent of the score of the
sixth factor.A good rating was reported if ® ve factors
scored three points or more, and the sixth factor two
points or less.A fair rating was regarded if ® ve of the
six factors scored one point or more, and the sixth
factor zero points. If two or more factors scored zero
points, the rating was considered poor.
Results
Surgical procedure
The 53 surgical procedures are listed in Table 2. All
CR of type IB, IC and II required restoration of the
pelvic girdle using auto- or allografts, plates, and/or
composite ® xations (Fig. 2). No reconstruction was
necessary in type IA resection and in three out of five
type III resections.
In 15 out of 17 patients, IH reconstruction was
performedby polyacetal pelvic replacement
16(Fig. 3),
in one case a saddle prosthesis and in one case a
computer-aided-designed pelvic replacement was
used.
In three out of the 13 cases of H, extended
Fig. 2. A 32-year-old woman with low-grade chondrosarcoma
arising from the right ilium; (a) pre-operative X-ray showing
calci® cations and displacement of the right ureter, (b) computed
tomography scan demonstrating the large extension of the tumor,
and (c) postoperative X-ray after continuity resection (type IB)
with restoration of the pelvic girdle by autograft and plates.
Fig. 3. A 29-year-old man with low-grade chondrosarcoma
arising from the right acetabulum; postoperative X-ray after
internal hemipelvectomy and restoration of the pelvic girdle by
polyacetal pelvic replacement.
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two cases, in one of them with additional partial
resection of the urinary bladder, and resection of the
rectum with subsequentcolostomyin one.Secondary
hemipelvectomy was necessary in three cases; one
due to local recurrence after CR, one due to local
recurrenceafter IH, and one due to chronic infection
after IH.
Surgical margin and tumor volume
The surgical margins in relation to the tumor stage
and the tumor volume are listed inTable 3. Margins
were wide in 27 cases, marginal in 16, and intral-
esional in eight.
In 21 small tumors, 14 margins were wide, ® ve
marginal, and two intralesional. In 30 large tumors,
13 margins were wide, 11 marginal, and six intral-
esional. In 26 low-grade tumors, there were 19 wide
and seven marginalmargins.In 25 high-gradetumors,
the margins were wide in eight cases, marginal in
nine, and intalesional in eight.
There was no statistical difference between the
tumor stage or volume and the obtainable surgical
margin.
The margins that could be obtained in the different
types of surgical procedure are demonstrated in
Table 4. There was also no signi® cant different
between the obtainable surgical margin and the
surgical treatment group.
Oncologic outcome
The actual oncologic status in relation to the tumor
stage, the surgical margin achieved, and the surgical
treatment group is also listed inTable 4.
Twenty-two patients show no evidence of disease,
four patients are disease free after local recurrence,
two patients are alive with metastases,and 22 patients
had died of disease. In one patient, follow-up and
actual oncologic status was not known.
Local recurrence and metastases
Excludingthe two stage IIIand three stage IA tumors,
Table 5 summarizesthe incidenceof local recurrence
and distant metastases in relation to the tumor stage,
surgical margin achieved, and the tumor volume.
Because two patients died perioperatively and
follow-up was not available in one patient, the
incidence of local recurrence and of metastases was
calculated on the basis of 48 patients.
Local recurrence occurred in 10 cases (20.8%),
with an average interval of 18.6 months (range 3± 36
Table 2. Surgical procedures
Reconstruction
n (=53) Resection Total None Auto-/
allograft
Composite
® xation
Plate
23 Continuity resection [5] 3 type IA 3
6 type IB 4 1 1
6 type IX 1 4 1
1 type II 1
5 type III 3 2
17 Internal hemipelvectomy* 15 polyacetal PR
1 CAD-PR
1 saddle prosthetic
13 Hemipelvectomy
*Two patients received internal hemipelvectomy after continuity resection. PR Pelvic replacement; CAD, computer-aided
design.
Table 3. Stage, tumor volume and achieved surgical margin
Volume Surgical margin
Stage n s (< 500 ml) l (‡ 500 ml) w m i
IA 3 3 3
IB 23 11 8 3
12 8 4
IIB 23 7 3 2 2
16 5 7 4
III 2 2 2
Total 51 18 33 27 16 8
s, small; l, large; w, wide; m, marginal; i, intralesional.
164 R.J.Wirbel et al.months). Four of them (40%) could be cured by
renewed resection; three after CR and one after IH.
Local recurrence was found in two patients who
underwent surgical procedure with a wide margin
(7.4%), whereas in six after resection with a marginal
margin.Thus, the incidence of local recurrence was
37.5%, when a marginal margin was achieved. Local
recurrencerate was not in¯ uencedby the tumor stage
and not signi® cantly by the tumor volume (22.% in
large tumors versus 20% in small tumors).
Distant metastases were foundin 17 cases (35.4%),
mostly recorded as pulmonary metastases (n=15).
The mean interval was 17.2 months (range 3± 48
months).Sixteen distant metastases occurredin stage
IIB tumors, whereas only one occurred in a stage IB
tumor.The incidence of distant metastases was not
in¯ uenced by the surgical margin achieved. Distant
metastases occurred more frequently in large tumors
(38.7%) than in small tumors(33.3%), but the differ-
ence was not signi® cant.
The incidence of local recurrence was dependent
signi® cantly upon the achieved surgical margin,
whereas the incidenceof distant metastases correlates
with the tumor stage (p=0.05).
Table 4. Oncologic outcome
Surgical procedure Margin Outcome
Stage n CR IH H w m i NED DFR ADM DOD
IA 3 1 2 3 3
IB 23 15 10 10
5* 1 2 1
6 4 3 1
2 1 1
2 2 2
IIB 23 7 1 1
3 1 1 1
3 3
7 4 1 3
3 1 2
3 3 1 2
3 3 6
III 2 2 2 2
Total 51 23 15 13 27 16 8 22 4 2 22
CR, Continuity resection;IH, internal hemipelvectomy;H, hemipelvectomy;w, wide; m, marginal; i, intralesional; NED, no
evidence of disease; DFR, disease free after local recurrence;ADM, alive with metastases; DOD, died of disease.
*In one of these patients, follow-up was not available.
Table 5. Occurrence of local recurrence (LR) and metastases (Met) in relation to tumor stage
and surgical margin achieved (stage III and IA tumors were excluded)
Outcome
n LR Met LR+Met DFR ADM DOD
Stage
IB 23 4 3 1
1 1
IIB 23 3 1 2
13 1 12
3 1 2
Margin
Wide 24 1 1
6 1 5
1 1
Margin 16 5 3 2
5 5
1 1
Intralesional 6 1 3 1 5
Volume
Small 15 2 4 1 7
Large 31 5 4 1
10 1 9
2 1 1
Total 46 7 14 3 4 2 18
DFR, Disease free after local recurrence;ADM, alive with metastases; DOD, died of disease.
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The overall survival analysis in relation to the tumor
stage and the surgical margin achieved are
demonstrated in Figures 4 and 5.
The best prognosis is seen in low-grade chondro-
sarcomaswith a 5-year survival of 95%,whereas high-
grade tumors survive only in 21%. The difference
was statistically signi® cant (p=0.05).
The difference of 5-year survival between achieved
wide margin (77%) and marginal margin (62.5%)
was not signi® cant. However, comparing intral-
esional resection (0% 5-year survival) with marginal
or wide resection shows a signi® cant difference
(p=0.05).
Survival was not in¯ uenced by the tumor volume,
the origin of the tumor, or the performed surgical
procedure.
Complications
Therewere two general(3.9%) and 20 local complica-
tions (39.2%).Two patients died peri-operatively;one
due to pulmonary embolism 10 days after surgery,
and one due to multiple organ failure 1 month post-
operatively.
Local infections and wound healing problems were
seen in 10 cases (18%); four after H (23%), three
after Ih (17.6%) and three after CR (13%).
After IH, four dislocations of the hip joint (23.5%)
could be treated by closed reduction. Four cases of
implant loosening, two after CR and two after IH,
required removal of the implant in two cases;
re-® xation was performed in one case after IH and in
one case after CR.
In one patient, peri-artiuclar ossi® cation around
the hip joint after IH was resected, but range of
motion of the hip joint remained restricted. Femoral
nerve palsy occurred in one patient after CR.
The complication rate was not signi® cantly
dependent upon the different surgical treatment
groups (i.e. CR, IH, and H).
Functional outcome
The functional results of the 28 survivors obtained at
the last follow-up are shown inTable 6 in relation to
the performed surgical procedure. The average
follow-up of these patients was 110 months (range,
4± 229 months).Good and excellentresultswere seen
in 19 cases (67.8%), fair in three (10.7%), and poor
in six (21.4%).
The mean MSTS score was 69.2% (range, 26.6±
100%). The best functional results were seen after
CR with a mean score of 79.5% (range, 40± 100%).
The score was not signi® cantly reduced in cases of
IH (61.4%; range, 26.6± 100%). As expected, all
patients who underwenthemipelvectomyshowed poor
functionalresultswith a mean score of 37.6% (range,
33± 40%).The different of MSTS scores between H
and CR or IH were statistically signi® cant (p=0.05).
Discussion
Chondrosarcomaarises in the pelvis in approximately
40± 50% of all chondrosarcomas.
1,2,4± 11,13± 16
Because there are no anatomical barriers in the
pelvis against expansion of the tumor, most pelvic
sarcomas producea large extraskeletal mass and have
to be classi® ed as extracompartmental.
A few articles
6,7,13,15 have analyzed the prognostic
factors that determine the outcome of patients with
chondrosarcoma of the pelvis. In our series, the
surgical margin obtained and the tumor stage were
the only two signi® cant prognostic factors. Like
reports by other authors,
6,7,13 the tumor volume had
no in¯ uence. In contrast to previous reports,
7 the
tumor’s epicenter was also not a prognostic factor in
our series.
An adequate surgical margin (i.e. wide or radical
margin) is considered the most important factor
associated with local tumor control.
1± 13,15 In the
pelvis, a wide margin is often difficult to obtain due
to adjacent visceral, vascular or neural structures.
The type of surgical treatment (limb sparing
procedure versus hemipelvectomy) had no in¯ uence
on the achieved surgical margin.
5± 7,13,15 It is the
adequacy of the surgical margin and not the type of
surgical procedure that is critical for local tumor
control.
The role of tumor grade for local tumor control in
chondrosarcomas is not clear.There exists only one
report
7 about the prognostic factor of tumor grade
upon local failure in chondrosarcoma of the pelvis.
Our ® ndings have con® rmed most previous studies
8±
11,13,15 that could not ® nd a relation between
incidence of local recurrence and tumor grade.
However, the overwhelming in¯ uence of tumor
Fig. 4. Kaplan± Meier survival analysis in relation to tumor
stage (stage III tumors were excluded).
Fig. 5. Kaplan± Meier survival analysis in relation to surgical
margin (stage III tumors were excluded).
166 R.J.Wirbel et al.stage on systemic failure (i.e. incidence of distant
metastases) indicates its signi® cance as a prognostic
factor that determines survival. In this regard, our
results agree with all previously published reports
chondrosarcoma at all sites
1± 5,8,10± 12 and in the
pelvis.
6,7,9,13± 15
Pritchard et al.
12 reported a better survival in
patients who underwentlimb sparing proceduresthan
in those who underwent hemipelvectomy. They
attributed this to a subtle selection bias, because the
only differences between the two groups were in the
mean age and sex.However,more patients with large
high-grade tumors underwent hemipelvectomy. On
multivariate analysis, tumor stage was the only
signi® cant prognostic factor.
The type of surgical procedure that should be
performed in pelvic malignancies depends mainly
upon the tumor localization and extension. For local
tumor control, the primary goal of resection is to
achieve an adequate surgical margin.
2,5,12,17 One of
the most critical areas to obtain an adequate margin
is the sacroiliac region. The ® ndings of a positive
surgical margin in the residual sacrum are consistent
with previous observations about pelvic
malignancies.
4± 7,9,13,15Furtherstudiesusingmagnetic
resonance imaging and CT scan have to be focused
on this area in question to stage, pre-operatively, the
exact sacral involvementof the tumor.The sectioning
of sacral roots or even a total sacrectomy should be
considered to control the tumor.These more radical
resections are easier in conjunction with extended
hemipelvectomy. Hemipelvectomy is further
indicated, when the sciatic nerve has to be sacri® ed,
the tumor invades the iliac vessels,or when resection
of large amounts of muscles leave the leg with poor
function.
7,9,13,15
When the tumor involves the ileum or the anterior
pelvic girdle without acetabular involvement,
continuity resection
4,5 is indicated. Restoration of
the pelvic girdle using allografts, autografts or
composite ® xations is necessary when the continuity
of the dorsal pelvic girdle is interrupted.
In acetabular lesions,internalhemipelvectomy and
endoprostheticreplacementby computer-aideddesign
prosthesis,
2,9,13,14,21 polyacetal pelvic replacement
15
or by the saddle prosthesis
22 ensure a primary ® xa-
tion with good functional results.
If, however, major parts of the ilium have to be
resected and proximal anchorage of the prosthesis
cannot be achieved, long-term stability cannot be
guaranteed.When proximal parts of the ilium can be
secured, new prosthetic devices with an intramedul-
lary ® xation by a spongy shaft may provide good
function and secondary ® xation by bone ingrowth.
21
Besides the tumor localization, other factors like
the functional result, the complication rate and the
oncologicprognosisjudgedthe tumorstage may in¯ u-
ence the choice of the surgical procedure.
Local complications after resection of pelvic
malignanciesare commonand have to be expected in
about 50% of cases.
4,5,7,13,14 In our series, the local
complication rate was 39.2%. Most local complica-
tions were caused by wound healing problems like
skin necrosis, sinuses and hematomas. In our series,
they were not signi® cantly in¯ uenced by the surgical
procedure.
The reasons for the high complication rate are not
in¯ uenced by the type of reconstruction, but rather
by the extentof the necessarysurgicalresection.Local
complications are considered to be attributed to the
large cavities due to extensive approaches and the
frequent tumor involvement of gluteal musclesor the
sciatic notch requiring transection of the glutal or
internal iliac vessels. Because of the often extensive
blood loss resulting in impaired coagulation, a
routinely performed second look operation washing
out the hematomas should be recommended in the
postoperative management after resection of pelvic
malignancies, and may help to reduce the local
complication rate.
The best functional results in our series were
achieved following continuity resections with a mean
MSTS score of 79.5% followed by internal hemipel-
vectomy and endoprosthetic replacement in
acetabular lesions with a mean score of 61.4%. These
® ndings are comparable with previous
reports.
4,5,9,11,13± 15
More restricted alternative procedures like
iliofemoral arthrodesis or pseudarthrosis
24 result in
either a considerable shortening of the leg or limited
mobility. Reconstruction by the saddle prosthesis
22
may be a good compromise between the achievable
function and the extent of the surgical procedure.
In low-grade pelvic chondrosarcomas, the excel-
lent oncologic prognosis (5-year survival of 95%)
justi® es adequate surgeryachieving wide margins and
Table 6. Functional results in 28 survivors of pelvic chondrosarcoma
Overall Enneking score
20
Surgical procedure n Excellent Good Fair Poor Mean MSTS score
20 (range)
Continuity resection 16 10 2 3 1 79.5% (40± 100%)
Internal hemipelvect. 9 2 5 2 61.4% (26.6± 100%)
Hemipelvectomy 3 3 37.6% (33± 40%)
Total 28 12 7 3 6 69.2% (26.6± 100%)
MSTS, MusculoskeletalTumor Society.
Chondrosarcoma of the pelvis 167restoration of the pelvic girdle by continuity resec-
tion or internal hemipelvectomy and endoprosthetic
replacement. In high-grade chondrosarcomas of the
pelvis, systemic failure led to a shortened survival in
the majority of patients (mean 5-year survival of 21%
in our series).
Because of this poor prognosis,however, the ques-
tion `how much’ surgery is justi® ed and necessary in
high-grade chondrosarcomasis still not answered and
extensively discussed.
4,5,7,15,22± 24
Because of the high incidence of metastases in
high-grade chondrosarcomas,there remains the hope
for an effective systemic therapy.
7
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